Crawford & Company: Competitive Benchmarking Report

The Business Analysts' Group
June 1, 2014
75 Pages - SKU: BAC6436933
CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2014
7/15/2014 | published by: Global Markets Direct
CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2014’, provides an overview of the CureFAKtor Pharmaceuticals. LLC’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Cellworks Group, Inc. - Product Pipeline Review - 2014
7/10/2014 | published by: Global Markets Direct
Cellworks Group, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Cellworks Group, Inc. - Product Pipeline Review - 2014’, provides an overview of the Cellworks Group, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
CytoTools AG - Product Pipeline Review - 2014
7/15/2014 | published by: Global Markets Direct
CytoTools AG - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘CytoTools AG - Product Pipeline Review - 2014’, provides an overview of the CytoTools AG’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Covalon Technologies Ltd. (COV) - Product Pipeline Analysis, 2014 Update
6/26/2014 | published by: GlobalData
Covalon Technologies Ltd. (COV) - Product Pipeline Analysis, 2014 Update Summary Covalon Technologies Ltd. (Covalon) is a healthcare service provider. The company research, develops and commercializes medical devices and healthcare technologies. It uses science and technology to  |  read more...
USD 750
CytoCore, Inc. (CYOE) - Product Pipeline Analysis, 2014 Update
6/26/2014 | published by: GlobalData
CytoCore, Inc. (CYOE) - Product Pipeline Analysis, 2014 Update Summary CytoCore, Inc. (CCI), formerly Molecular Diagnostics, Inc., is a biotechnology company. It undertakes the design, development and commercialization of cost-effective screening systems for the early detection of  |  read more...
USD 750
Insurance Agencies, Risk Management Consultants and Insurance Brokers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 524210
6/30/2014 | published by: Plunkett Research, Ltd.
Insurance Agencies, Risk Management Consultants and Insurance Brokers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 524210 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will  |  read more...
USD 1,995
Life Insurance and Annuity Underwriters (Direct Carriers) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 524113
6/30/2014 | published by: Plunkett Research, Ltd.
Life Insurance and Annuity Underwriters (Direct Carriers) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 524113 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save  |  read more...
USD 1,995
EXL - Auto Insurance BPO
6/11/2014 | published by: NelsonHall
EXL - Auto Insurance BPO Who Is This Vendor Assessment For? NelsonHall’s Auto Insurance BPO profile on EXL is a comprehensive assessment of EXL’s offerings and capabilities designed for: Sourcing managers monitoring the capabilities of existing  |  read more...
USD 1,200
Cardio3 BioSciences SA - Product Pipeline Review - 2014
6/15/2014 | published by: Global Markets Direct
Cardio3 BioSciences SA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Cardio3 BioSciences SA - Product Pipeline Review - 2014’, provides an overview of the Cardio3 BioSciences SA’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Cellceutix Corporation - Product Pipeline Review - 2014
6/25/2014 | published by: Global Markets Direct
Cellceutix Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Cellceutix Corporation - Product Pipeline Review - 2014’, provides an overview of the Cellceutix Corporation’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 1,799  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!